The superficial femoral artery (SFA) poses unique challenges for endovascular stenting. It is a long, muscular artery that is fixed between the hip and the knee; as a result of the complex motions of the hip joint, the SFA is subject to unique forces, including flexion, extension, and …

Percutaneous transluminal angioplasty of superficial femoral artery is a proven, viable, safer, and effective option, with good mid-term clinical results and patency rates. Different approaches to be chosen depends on the anatomical and technical factors to get the best possible outcome.

Diagnostic iliac, femoral, and popliteal angiograms are performed to assess the extent and burden of disease. Given that the disease is limited to the mid to distal femoral artery, a decision is made to undergo balloon angioplasty and subsequent stent insertion with a Viabond stent graft.

2019年1月10日 · Arterial access is gained by surgical cutdown or percutaneous approach. The surgical approach has a relatively high local complication rate. We describe superficial femoral artery (SFA) access as an alternative to CFA exposure to minimize wound complications and to facilitate swift recovery.

Subintimal angioplasty is an effective method for the treatment of long superficial femoral artery (SFA) occlusions. One of the major limiting factors for the success of this procedure is the failure to re-enter the true lumen. The recently introduced luminal re-entry devices provide a high technical success rate, but failures can occur.

PTA and stenting of the SFA can be performed safely with excellent procedural success rates. Improved patency of these interventions was seen with increased ankle/brachial index and the performance of angioplasty only.

Endovascular intervention is commonly pursued as first-line management of symptomatic, long-segment superficial femoral artery (SFA) disease. The relative effectiveness and comparative long-term outcomes among bare metal stents (BMS), covered stents (CS), and drug-eluting stents (DES) for long-segment SFA lesions remain uncertain.

During the past decade, multiple technologies have been developed for treatment of superficial femoral artery (SFA) atherosclerotic disease, including balloon angioplasty, bare nitinol self-expanding stents, drug-eluting nitinol stents, and drug-coated balloons.

Thrombotic occlusion of the superficial femoral artery (SFA) is still a major cause of limb ischemia and loss. Conventional treatment includes thrombo-embolectomy with a Fogarty catheter or surgical bypass, while loco-regional pharmacologic thrombolysis is an alternative therapy [1].

2014年9月4日 · In summary, this retrospective review of a preliminary SFA PEVAR case series suggests that, in the absence of a healthy or percutaneously accessible CFA, PEVAR procedures performed with the use of an appropriate SFA target are safe for up to 20-French access—when combined with intraoperative duplex ultrasound (both before and after the ...